Latest FDA Approvals: Ensartinib, Subcutaneous Nivolumab, and Encorafenib for NSCLC, CRC & Melanoma | VuMedi

Find latest Non-Small Cell Lung Cancer videos · 600+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

OncoPharm

Latest FDA Approvals: Ensartinib, Subcutaneous Nivolumab, and Encorafenib for NSCLC, CRC & Melanoma

By OncoPharm FEATURING John Bossaer

By OncoPharm FEATURING John Bossaer

23 views

February 5, 2025

Comments 0

Login to view comments. Click here to Login